In vitro research indicates that BHT may inhibit HSV replication, but these results lack confirmation in living organisms or human trials. More research is needed to validate this benefit.
In vitro studies suggest Butylated Hydroxytoluene (BHT) may inhibit the replication of the Herpes Simplex Virus (HSV). The mechanism involves interference with the viral envelope or replication process. However, this effect has not been consistently demonstrated in in vivo studies or human clinical trials.
Ingredients That Provide This Benefit
Evidence Levels for Ingredients
Butylated Hydroxytoluene (BHT)
Evidence: 2/5